6 ASX All Ords Shares Lifted to 'Strong Buy' Consensus Ratings for the New Year

The Motley FoolJan 1 18:56 ET

Paradigm Biopharmaceuticals Issues New Performance Rights

TipRanksDec 20, 2024 00:28 ET

Paradigm Biopharmaceuticals to Raise AU$16 Million via Share Placement; Shares Down 6%

MT NewswiresDec 8, 2024 22:04 ET

Why ANZ, Calix, Paradigm, and Platinum Shares Are Tumbling Today

The Motley FoolDec 8, 2024 21:01 ET

Paradigm Biopharma Highlights Investment Risks and Cautions

TipRanksDec 8, 2024 19:08 ET

Paradigm Biopharmaceuticals Secures $16M for Global Trials

TipRanksDec 8, 2024 18:48 ET